Orthopaedic Surgery Department, Hamad General Hospital, PO Box 3050, Doha, Qatar.
Int Orthop. 2020 Dec;44(12):2701-2708. doi: 10.1007/s00264-020-04745-0. Epub 2020 Oct 3.
To compare the rates of ulnar nerve neuropathy following ulnar nerve subcutaneous anterior transposition versus no transposition during open reduction and internal fixation (ORIF) of distal humerus fractures.
This was a retrospective cohort study at an academic level I trauma centre. A total of 97 consecutive patients with distal humerus fractures underwent ORIF between 2011 and 2018. All included patients were treated with plates (isolated lateral plates excluded) and had no pre-operative ulnar neuropathy. Subcutaneous ulnar nerve anterior transposition was compared versus no transposition at the time of ORIF. The main outcome measure was the rate of ulnar nerve neuropathy. The secondary outcomes were the severity of the ulnar nerve neuropathy and the rate of ulnar nerve recovery.
Twenty-eight patients underwent subcutaneous ulnar nerve anterior transposition during ORIF, whereas 69 patients had no transposition. Transposition was associated with significantly higher rates of ulnar nerve neuropathy (10/28 versus 10/69; P = 0.027). An adjusted logistic regression model demonstrated an odds ratio of 4.8 (1.3, 17.5; 95% CI) when transposition was performed. Ulnar nerve neuropathy was classified as McGowan grades 1 and 2 in all neuropathy cases in both groups (P = 0.66). Three out of ten cases recovered in the transposition group, and five out of ten cases recovered in the no transposition group over a mean follow-up of 11.2 months (P = 1.00).
We do not recommend performing routine subcutaneous ulnar nerve anterior transposition during ORIF of distal humerus fracture as it was associated with a significant 5-fold increase in ulnar nerve neuropathy.
比较尺神经皮下前置与不前置在前臂骨远端骨折切开复位内固定(ORIF)术中治疗尺神经病变的发生率。
这是一项在学术一级创伤中心进行的回顾性队列研究。共纳入 97 例连续接受 ORIF 治疗的尺骨远端骨折患者,其手术时间为 2011 年至 2018 年。所有纳入患者均接受了钢板治疗(排除单独使用外侧钢板的病例),且术前无尺神经病变。比较 ORIF 时行皮下尺神经前置与不行前置的尺神经病变发生率。主要结局指标为尺神经病变发生率。次要结局指标为尺神经病变严重程度和尺神经恢复率。
28 例患者在 ORIF 时行皮下尺神经前置,69 例患者未行前置。行前置与未行前置患者的尺神经病变发生率差异有统计学意义(10/28 与 10/69;P=0.027)。校正后的逻辑回归模型显示,行前置时发生尺神经病变的优势比为 4.8(1.3,17.5;95%CI)。两组所有尺神经病变病例均为 McGowan 分级 1 级和 2 级(P=0.66)。在前置组中,10 例尺神经病变中有 3 例恢复,而在未前置组中,10 例尺神经病变中有 5 例恢复,平均随访时间为 11.2 个月(P=1.00)。
我们不建议在 ORIF 治疗尺骨远端骨折时常规行皮下尺神经前置,因为这会显著增加 5 倍的尺神经病变风险。